The rulebook for rare disease treatments will be overhauled to make it quicker and easier to get these therapies tested, ...

Swiss pharma major Roche (ROG: SIX) has reported positive Phase III data for Gazyva (obinutuzumab) in systemic lupus ...

Irish healthcare group Uniphar (LSE: UPR) has unified its US businesses under one banner, rebranding RRD Biopharma ...

UK-based specialty CNS-focused pharma company CNX Therapeutics says it has acquired the global Sativex (nabiximols) business ...

Germany-based Immatics has this month announced updated clinical data from its PRAME-directed TCR T-cell therapy, anzu-cel (anzutresgene autoleucel, IMA203), in 16 patients with metastatic uveal ...

Pfizer today announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk in the US District Court for the District of Delaware.

Pharmacovigilance (PV) is a crucial process used by pharmaceutical companies, healthcare professionals and regulators in identifying, evaluating and preventing adverse drug reactions.

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to challenge multinational dominance.

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

Germany-based biotech Tubulis today announced a second and final closing of its Series C round totaling 344 million euros ...

US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...

Merck & Co (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, while adjusted earnings rose ...